1
/
of
1
Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME)
TRV-007814-01
Antibodies
Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME)
SKU:TRV-007814-01
Regular price
$98.30
Regular price
Sale price
$98.30
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
Related categories:
Antibodies
Share

Product specifications
| Alternative Name | MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors |
| Name Synonym | Preferentially Expressed Antigen In Melanoma |
| Uniprot | P78395 |
| Field of Research | Tumor immunity |
| Applications | WB; IHC; ICC/IF |
| Organism Species | Homo sapiens (Human) |
| Reactivity | Po |
| Concentration | 0.5mg/mL |
| Buffer | PBS, pH7.4, containing 0.02% NaN3, 50% glycerol. |
| Host | Rabbit |
| Host or Source | Rabbit |
| Source | Polyclonal antibody preparation |
| Immunogen | RPH323Hu01-Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) |
| Recommended Usage | Western blotting: 0.01-2µg/mL< br/> Immunohistochemistry: 5-20µg/mL< br/> Optimal working dilutions must be determined by end user. |